Amgen GmbH

Biotechnology, Medical Technology

  • Short facts

    • Manufacturer
  • Year founded 1989
  • 315 Employees (site)
  • Turnover: 50m <125m EUR

Products/services: Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses.

Basic data

Company

Amgen GmbH

Street

Riesstraße 24

PC / City

80992 München

County

Upper Bavaria

Phone

+49 89 149096-0

Fax

+49 89 149096-2000

Email

Language skills

English, German

Profile/competences

Core competencies

Amgen's corporate mission is to be the world leader in developing and delivering important, cost-effective therapeutics based on cellular and molecular biology. The company's first product, EPOGEN® (Epoetin alfa), stimulates and regulates the production of red blood cells. Amgen's second product, NEUPOGEN® (Filgrastim), is a recombinant granulocyte colony-stimulating factor (G-CSF) that selectively stimulates growth of infection-fighting white blood cells known as neutrophils. In 2001 Amgen launched a new drug, called Aranesp®, which also stimulates the production of red blood cells. Aranesp® was created by rational drug design and has a threefold longer halflife time compared to Epogen®. In 2002 AMGEN launched a second generation G-CSF called Neulasta® which also stimulates the growth of neutrophils. Neulasta® has an important advantage. Due to its pegylation Neulasta® has a longer half-life time and therefore has to be administered only once per chemotherapy cycle whereas Neupogen® has to be administered daily.

Key sectors / sub-sectors

  • Biotechnology: Molecular diagnostics for humans
  • Biotechnology: Therapeutic drug development
  • Medical Technology: Technical services for medical technology

NACE industries

  • Wholesale of chemical products 46.75

Certifications / awards

not available

Sales markets - target industries

not available

Sales markets - target countries

not available

Cooperation offers

not available